by Nanospeed-admin | Feb 14, 2022 | Uncategorized
NanoSpeed Diagnostics Inc. to participate in the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo Edmonton, July 24, 2015 – NanoSpeed Diagnostics Inc. will participate in the 2015 AACC Annual Meeting and Clinical Lab Expo....
by Nanospeed-admin | Feb 14, 2022 | Uncategorized
NanoSpeed Diagnostics enters into Research Collaboration with Dynalife Dx EDMONTON, Alberta – (January 18, 2016) – NanoSpeed Diagnostics Inc. (“NanoSpeed”) is pleased to announce a new multi-year research collaboration with Dynalife Dx Inc. (“Dynalife”) to develop new...
by Nanospeed-admin | Feb 14, 2022 | Uncategorized
NanoSpeed Diagnostics Inc. to participate in Arab Health 2016 Edmonton, January 18, 2016 – NanoSpeed Diagnostics Inc. will participate in Arab Health 2016. The Arab Health 2016 exhibition will showcase more than 4,000 companies exhibiting their latest innovations to...
by Nanospeed-admin | Feb 14, 2022 | Uncategorized
NanoSpeed Diagnostics and Test4D™ achieves major sales milestone EDMONTON, Alberta – NanoSpeed Diagnostics Inc. (“NanoSpeed” or “the Company”) is pleased to announce that Test4D™, the world’s first point-of-care test for vitamin D...
by Nanospeed-admin | Feb 14, 2022 | Uncategorized
NanoSpeed Diagnostics: 2016 Alberta Export Award Finalist EDMONTON, Alberta – (November 2, 2016) – NanoSpeed Diagnostics Inc. (“NanoSpeed” or “the Company”) is pleased to announce that it was chosen to be a finalist in the category of Advanced Technology and...
by Nanospeed-admin | Feb 14, 2022 | Uncategorized
Groundbreaking Ceremony for new NanoSpeed R&D Facility NanoSpeed Diagnostics Inc. will be moving into a new two storey 11,000 sqft R&D and manufacturing facility in Edmonton Research Park. Two factors played a key role for the site selection: Research Park is...
